The Biolocity Team is excited to partner with Additional Ventures to assist in identifying promising research at both Georgia Tech and Emory University that provides solutions for single ventricle heart defects. To learn about this partnership, read more here.
Biolocity’s annual funding cycle is now open for the acceleration of university innovations! Faculty in search of funding and commercialization guidance to meet strategic development milestones for commercial success are encouraged to apply.
Faculty at Georgia Tech, Emory University, and Georgia State University have been selected to receive a broad range of support from Biolocity to accelerate the commercialization of their patient impacting technologies. During their funding period, each team will receive project management and work directly with business experts and consultants to de-risk their technology and advance its development.
Powered by WordPress & Theme by Anders Norén
You must be logged in to post a comment.